Clinical Trial Update: To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy of the investigational product(s) versus placebo in idiopathic pulmonary fibrosis was terminated; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Investigational product(s) for IPF

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: TERMINATED | Results posted: 2025-09-18